Grifols
ALPHANATE
Manufacturer:
Grifols
Name:
ALPHANATE
HCPCS Code Descriptor:
Injection, antihemophilic factor viii/von willebrand factor complex (human), per factor viii i.u.
Category:
J Code
HCPCS:
J7186
NDC(s):
68516-4620-02, 68516-4616-01, 68516-4617-01, 68516-4618-02, 68516-4619-02, 68516-4611-01, 68516-4612-01, 68516-4615-02, 68516-4614-02, 68516-4613-02, 68516-4609-02, 68516-4604-02, 68516-4601-01, 68516-4602-01, 68516-4603-02
Primary Type:
Hematology
Generic Status:
Single-Source
Route of Administration:
Intravenous
About:
ALPHANATE is a Hematology drug manufactured by Grifols and administered via the Intravenous route of administration. The J Code: J7186 is aligned to the drug ALPHANATE.
Access Pricing and More By Registering
HCPCS Added Date:
1/1/09
HCPCS Effective Date:
1/1/09
HCPCS Short Description:
Antihemophilic viii/vwf comp
Billing and Coding Guide:
https://www.alphanate.com/documents/729928/730168/Alphanate+Coding+and+Billing+Chart.pdf/a1336d88-3ec2-453a-ba89-94d76befba7a?t=1584613068561
Patient Assistance:
Not Found